Zobrazeno 1 - 6
of 6
pro vyhledávání: '"CNKI, Chinese National Knowledge Infrastructure"'
Autor:
Zhuang, Jieqin, Dai, Xingzhen, Jin, Zilin, Cai, Hairong, Wu, Qihua, Zhang, Weizhang, Gao, Huanjia, Chen, Bojun
Publikováno v:
Complementary Therapies in Medicine, Vol 60, Iss, Pp 102754-(2021)
Complementary Therapies in Medicine
Complementary Therapies in Medicine
BACKGROUND: Traditional Chinese medicine (TCM) has been proven to played a great important role on the treatment of COVID-19. As one of the drugs recommended in Chinese guidelines, Lianhua Qingwen Granules or Capsules (LQ) are widely used.This system
Publikováno v:
Meta Gene
Background The association between G protein β-polypeptide 3 gene (GNB3) c.825C > T polymorphism (rs5443) and the risk of overweight/obesity has been investigated in many published studies, but the results were conflicting and inconclusive. A meta-a
Publikováno v:
Metabolism
Background Obesity is common in patients with coronavirus disease 2019 (COVID-19). The effects of obesity on clinical outcomes of COVID-19 warrant systematical investigation. Objective This study explores the effects of obesity with the risk of sever
Publikováno v:
Meta Gene
Background Emerging evidence has shown that p53 gene participates in human carcinogenesis as tumor suppressors. Polymorphism of p53 gene codon 72 Arg/Pro (rs1042522) may influence the function of p53 protein and then affect the processing of carcinog
Autor:
Li HL; Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, Hunan, PR China; School of Pharmaceutical Science, Central South University, Changsha 410013, Hunan, PR China., Zhang YJ; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410078, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, PR China., Chen XP; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410078, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, PR China., Luo JQ; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410078, PR China; Institute of Clinical Pharmacology, Central South University, Hunan Key Laboratory of Pharmacogenetics, Changsha 410078, PR China., Liu SY; School of Public Health, Central South University, Changsha 410078, Hunan, PR China., Zhang ZL; Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, Hunan, PR China.
Publikováno v:
Meta gene [Meta Gene] 2016 Mar 18; Vol. 9, pp. 18-25. Date of Electronic Publication: 2016 Mar 18 (Print Publication: 2016).
Autor:
Hu S; Department of Geriatrics, Changzhou NO 2 People's Hospital, Affiliated Hospital of Nanjing Medical University, Changzhou, China., Zhao L; Kunshan Agency for Public Health Inspection, Soochow, China., Yang J; Department of Geriatrics, Changzhou NO 2 People's Hospital, Affiliated Hospital of Nanjing Medical University, Changzhou, China., Hu M; Department of Geriatrics, Changzhou NO 2 People's Hospital, Affiliated Hospital of Nanjing Medical University, Changzhou, China.
Publikováno v:
Meta gene [Meta Gene] 2013 Oct 30; Vol. 1, pp. 126-37. Date of Electronic Publication: 2013 Oct 30 (Print Publication: 2013).